Prof. Dr. Faruk TAŞ

American journal of therapeutics , 2025 (SCI-Expanded)

2. Temozolomide After Excision of Lung Metastases in Patients With Melanoma.

American journal of therapeutics , 2025 (SCI-Expanded)

3. Sex Difference Has No Effect on Survival in Pancreatic Cancer

Taş F., Erturk K.

INDIAN JOURNAL OF SURGICAL ONCOLOGY , 2025 (ESCI)

4. Access to current medicines in the treatment of Turkish melanoma patients.

Tas F., Yolcu Z.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , 2025 (SCI-Expanded)

5. Age-related Survival Declines in Turkish Patients with Cutaneous Melanoma: A Retrospective Analysis

TAŞ F., Erturk K.

Dermatology Practical and Conceptual , cilt.15, sa.2, 2025 (SCI-Expanded)

6. Effects of Home-Based Exercise Program on Chemotherapy-Induced Peripheral Neuropathy and Quality of Life: A Single-blind Randomized Controlled Trial.

Çömlekçi N., Can G., Taş F.

Cancer nursing , 2025 (SCI-Expanded)

7. Nivolumab-induced immune-mediated acute gastritis in a melanoma patient.

Tas F., Ahishali E., Taskin O. C.

Melanoma research , 2025 (SCI-Expanded)

8. Effects of Age, Gender, Histopathology, and Anatomical Location of the Lesion on BRAF Mutation in Turkish Cutaneous Melanoma Patients

TAŞ F.

INDIAN JOURNAL OF SURGERY , 2025 (SCI-Expanded)

9. LYVE-1 MOLEKÜLÜ İLERİ EVRE AKCİĞER KANSERLİ HASTALARDA TANISAL BİR BİYOBELİRTEÇ OLABİLİR Mİ?

Serilmez M., Özgür E., Soydinç H., Tilgen Yasasever C., Taş F., Gezer U., et al.

Sabiad , cilt.8, sa.1, ss.7-14, 2025 (TRDizin)

10. Brain metastases during follow-up of patients with resected cutaneous melanoma.

Altan Ferhatoglu Z., Tas F.

Melanoma research , 2025 (SCI-Expanded)

11. A melanosis patient with primary unknown metastatic melanoma: successful treatment with BRAF/MEK inhibitors

TAŞ F.

JOURNAL OF THE SCIENTIFIC SOCIETY , 2025 (ESCI)

12. Avoiding Cutaneous Melanoma Requires Proper Sun Protection and a Correspondingly High Level of Education: A Case Control Study.

Journal of cosmetic dermatology , 2024 (SCI-Expanded)

13. Clinical significances of TTF-1, neuroendocrine (chromogranin, synaptophysin, CD56), and keratin (pancytokeratin, CK7, CK5/6) marker immunostaining in small cell lung cancer.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico , 2024 (SCI-Expanded)

14. Female Patients with Small Cell Lung Cancer Have Better Survival than Males with Extensive but Not Limited Disease.

Oncology research and treatment , ss.1-7, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

15. Prognostic significance of body mass index and serum albumin as the indicators of nutritional status in small cell lung cancer.

Postgraduate medicine , 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

16. Comorbidity in Small Cell Lung Cancer: Prognostic Impacts of Hypertension/Coronary Artery Disease, Diabetes Mellitus, and Chronic Obstructive Pulmonary Disease.

Cancer investigation , ss.1-13, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

17. A Modified H-index Calculated Using the Duration of Professional Experience and the Author's Significant Contribution to Publications.

Cureus , cilt.16, sa.1, 2024 (ESCI)

18. Timing of chemotherapy after diagnosis of small cell lung cancer.

Journal of chemotherapy (Florence, Italy) , ss.1-6, 2024 (SCI-Expanded, Scopus)

19. Effect of Histological Subtype on Metastasis Distribution in Resected Cutaneous Melanoma

INDIAN JOURNAL OF DERMATOLOGY , cilt.69, sa.1, ss.107, 2024 (SCI-Expanded)

20. Median Age of Cutaneous Melanoma Presentation in Turkey from a Single Tertiary Center Is Younger Than Other Western Countries

TAŞ F., Erturk K.

INDIAN JOURNAL OF SURGERY , cilt.85, sa.4, ss.1010-1011, 2023 (SCI-Expanded, Scopus)

21. Neither the presence nor the severity of hyponatremia affected the outcome of the patients with small cell lung cancer.

TAŞ F., KIZILDAĞ YIRGIN İ.

Irish journal of medical science , cilt.192, sa.4, ss.1613-1619, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Intraabdominal splenosis due to traffic accident

TRAUMA-ENGLAND , sa.3, ss.275-276, 2023 (ESCI) Sürdürülebilir Kalkınma

23. Breast cancer patients are diagnosed at younger ages in Turkey: a comparative study.

Irish journal of medical science , cilt.192, sa.3, ss.1073-1075, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

24. Completion Lymph Node Dissection Is Unnecessary After Positive Sentinel Lymph Node in Melanoma — a Case Series Analysis

TAŞ F., Erturk K., Ferhatoglu F.

Indian Journal of Surgery , cilt.85, sa.3, ss.570-574, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

25. Cutaneous melanoma survival rates of the elderly are not worse than those of the young, yet they have some specific differences

Ferhatoglu F., Erturk K., Taş F.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.19, sa.(Suppl 1), ss.349-354, 2023 (SCI-Expanded)

26. Turkey's contribution to cancer publication: Expected quantity, unsatisfactory quality.

Journal of cancer research and therapeutics , cilt.19, sa.Supplement, 2023 (SCI-Expanded)

27. Using Google as a Source of Information About Breast Cancer

INDIAN JOURNAL OF SURGERY , cilt.85, sa.2, ss.473-475, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

28. Primary tumor SUV(max) and ratio of SUV(max) to primary tumor size on pretreatment 18F-FDG-PET/CT scan in small cell lung cancer : Which is superior for the prognosis?

Wiener klinische Wochenschrift , 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

29. Diagnosing lung cancer at a younger age and with male dominance: Comparison of Turkish patients with United States patients.

Journal of cancer research and therapeutics , cilt.19, sa.Suppl 2, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

30. Melanoma publications do not increase as much as the incidence of melanoma in the last two decades.

Journal of cancer research and therapeutics , cilt.19, sa.Suppl 2, 2023 (SCI-Expanded)

31. Online public interest in smoking and lung cancer: A comparative study in Google Trends.

Journal of cancer research and therapeutics , cilt.19, sa.Suppl 2, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

32. Seasons Influence Diagnosis of Breast Cancer in Turkey

Taş F., Erturk K.

INDIAN JOURNAL OF SURGERY , cilt.84, sa.6, ss.1364-1365, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

33. Major Histotypes in Skin Melanoma: Nodular and Acral Lentiginous Melanomas Are Poor Prognostic Factors for Relapse and Survival.

The American Journal of dermatopathology , cilt.44, ss.799-805, 2022 (SCI-Expanded, Scopus)

34. Successful Treatment of a 92-Year-Old Classic Kaposi's Sarcoma Man With Ultra-Low Dose Oral Etoposide.

Tas F., Sakar B.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , cilt.28, sa.7, ss.1671-1673, 2022 (SCI-Expanded)

35. Unknown Primary Metastatic Melanoma Presented with Extensive Subcutaneous Masses and Lymph Node Enlargements

INDIAN JOURNAL OF SURGERY , cilt.84, ss.579-580, 2022 (SCI-Expanded)

36. Larger Tumors Are Associated with Poorer Prognostic Factors in Cutaneous Melanoma

INDIAN JOURNAL OF SURGERY , cilt.84, sa.3, ss.591-594, 2022 (SCI-Expanded)

37. Digit melanomas are associated with poor prognostic factors and unfavorable survivals.

Journal of cosmetic dermatology , cilt.21, ss.2120-2129, 2022 (SCI-Expanded, Scopus)

38. Different mitotic rates are associated with different prognostic factors, relapses, and survival rates in melanoma.

International journal of dermatology , cilt.61, sa.4, ss.472-479, 2022 (SCI-Expanded, Scopus)

39. Auricular and periauricular melanomas have similar clinicopathologic factors and survival rates.

Tas F., Erturk K., Ferhatoglu F.

Journal of cosmetic dermatology , cilt.21, sa.4, ss.1570-1573, 2022 (SCI-Expanded)

40. Complementary and alternative medicine (CAM) in Turkish cutaneous melanoma patients: A prospective study from tertiary cancer center.

Tas F., Cinar E., Erturk K.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , cilt.28, sa.2, ss.282-286, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

41. Ulceration vs Mitosis in Cutaneous Melanoma: which is Superior for Predicting Prognosis Across Clinical Stages?

Cancer investigation , cilt.40, ss.842-851, 2022 (SCI-Expanded)

42. Limb melanomas: acral melanomas have worse survival.

The Journal of dermatological treatment , cilt.33, sa.3, ss.1630-1637, 2022 (SCI-Expanded, Scopus)

43. Trunk melanomas: no survival differences between lesion sites.

Postgraduate medicine , cilt.134, sa.6, ss.609-615, 2022 (SCI-Expanded)

44. Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: retrospective real-life data.

Gürbüz M., Doğan İ., Akkuş E., Ermiş H., Utkan G., Taş F., et al.

Dermatologic therapy , cilt.34, sa.6, 2021 (SCI-Expanded, Scopus)

45. Serum folate and vitamin B12 levels in cutaneous melanoma

Tas F., Erturk K., Soydinc H.

JOURNAL OF COSMETIC DERMATOLOGY , cilt.20, sa.9, ss.3007-3010, 2021 (SCI-Expanded, Scopus)

46. Coexistence of regression and tumor infiltrating lymphocytes is associated with more favorable survival in melanoma.

Journal of cancer research and clinical oncology , cilt.147, ss.2721-2729, 2021 (SCI-Expanded, Scopus)

47. Trends in the characteristics of skin melanoma in accordance with time intervals: A single Turkish tertiary referral center experience.

Journal of cancer research and therapeutics , cilt.17, sa.4, ss.1119-1122, 2021 (SCI-Expanded, Scopus)

48. Mitotic rate in node-positive stage III melanoma: it might be as important a prognostic factor as node number.

Japanese journal of clinical oncology , cilt.51, ss.873-878, 2021 (SCI-Expanded, Scopus)

49. Multiple combinations of melanocytic and vascular endothelial markers enhance the detection rate of lymphovascular invasion in cutaneous melanoma.

Bayram A., Sari S., Ozluk Y., Tas F., Buyukbabani N.

Journal of cutaneous pathology , cilt.48, sa.4, ss.472-478, 2021 (SCI-Expanded, Scopus)

50. Primary tumour ulceration in cutaneous melanoma: its role on TNM stages.

Japanese journal of clinical oncology , cilt.51, ss.192-198, 2021 (SCI-Expanded, Scopus)

51. Single-agent temozolomide may be an effective option for late adjuvant therapy in patients with melanoma.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , cilt.27, sa.1, ss.40-45, 2021 (SCI-Expanded, Scopus)

52. Serum 25-Hydroxyvitamin D Level Is Not Associated with Duration and Activity of Disease in Melanoma Patients

Tas F., Erturk K., Oguz S.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL , cilt.73, sa.7, ss.1126-1129, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

53. Paradox in melanoma: more patients fewer publications.

Melanoma research , cilt.30, ss.632, 2020 (SCI-Expanded, Scopus)

54. Google searching as an indicator of population's interest in melanoma: A comparative study in Google Trends.

Dermatologic therapy , cilt.33, 2020 (SCI-Expanded, Scopus)

55. Awareness on malignant melanoma and its prevention measures among Turkish cutaneous malignant melanoma patients: A tertiary cancer center experience.

Tas F., Cinar F., Erturk K.

Dermatologic therapy , cilt.33, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

56. Cutaneous melanoma in vicenarians: Patients in their twenties and older patients show similar clinical behaviors and survival rates

JOURNAL OF COSMETIC DERMATOLOGY , cilt.19, ss.2692-2696, 2020 (SCI-Expanded, Scopus)

57. De Novo and Nevus-Associated Melanomas: Different Histopathologic Characteristics but Similar Survival Rates.

Pathology oncology research : POR , cilt.26, ss.2483-2487, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

58. SEASONS INFLUENCE DIAGNOSIS AND OUTCOME OF CUTANEOUS MELANOMA.

Dermatologic therapy , cilt.33, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

59. BRAF V600E mutation as a prognostic factor in cutaneous melanoma patients.

Dermatologic therapy , cilt.33, 2020 (SCI-Expanded, Scopus)

60. Spitzoid cutaneous melanoma is associated with favorable clinicopathological factors and outcome.

Journal of cosmetic dermatology , cilt.18, ss.1841-1845, 2019 (SCI-Expanded, Scopus)

61. Distichiasis in association with entropion in metastatic HER2-positive breast cancer treated by pertuzumab, trastuzumab, and docetaxel combination chemotherapy

Tas F., Ozturker C.

BREAST JOURNAL , 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

62. Number of Excised Lymph Nodes Has No Impact on Relapse and Survival in Patients With Stage III Melanoma

ANNALS OF PLASTIC SURGERY , cilt.83, sa.4, ss.455-458, 2019 (SCI-Expanded, Scopus)

63. BRAF mutation status might contribute an effect on both disease-free and overall survival in stage III cutaneous melanomas treated with intermediate dose interferon-alpha

CANCER CHEMOTHERAPY AND PHARMACOLOGY , cilt.84, sa.3, ss.521-526, 2019 (SCI-Expanded, Scopus)

64. Serum nectin-2 and nectin-4 are diagnostic in lung cancer: which is superior?

Erturk K., Karaman S., Dagoglu N., Serilmez M., Duranyildiz D., Tas F.

WIENER KLINISCHE WOCHENSCHRIFT , sa.17-18, ss.419-426, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

65. Clinical and prognostic significance of BRAF V600E mutation in non-metastatic cutaneous melanoma patients.

Neoplasma , cilt.66, sa.4, ss.631-636, 2019 (SCI-Expanded, Scopus)

66. The course of stage III melanoma in accordance with the severity of node involvement

CURRENT MEDICAL RESEARCH AND OPINION , cilt.35, sa.10, ss.1819-1824, 2019 (SCI-Expanded, Scopus)

67. Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , cilt.24, sa.6, ss.721-726, 2019 (SCI-Expanded, Scopus)

68. Early and late relapses of cutaneous melanoma patients

POSTGRADUATE MEDICINE , cilt.131, sa.3, ss.207-211, 2019 (SCI-Expanded, Scopus)

69. Relapse patterns in patients with local and regional cutaneous melanoma.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico , cilt.21, sa.4, ss.412-419, 2019 (SCI-Expanded, Scopus)

70. Cheek Cutaneous Melanomas A Review of 98 Cases

ANNALS OF PLASTIC SURGERY , cilt.82, sa.4, ss.407-410, 2019 (SCI-Expanded, Scopus)

71. Prognostic and Predictive Role of Angiogenic Markers in Non- Small Cell Lung Cancer

Keskin S., Kutluk A., Tas F.

Asian Pacific journal of cancer prevention : APJCP , cilt.20, ss.733-736, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

72. Palpebral cutaneous melanomas: a review of 17 cases from a tertiary center

INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.58, sa.1, ss.75-79, 2019 (SCI-Expanded, Scopus)

73. Clinical significance of serum caveolin-1 levels in gastric cancer patients.

Tas F., Karabulut S., Erturk K., Duranyildiz D.

Experimental oncology , cilt.40, ss.323-327, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

74. Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer

Afsar C. U., Karabulut M., Karabulut S., Ozal S. T., Cikot M., Serilmez M., et al.

BIOMOLECULES , cilt.8, sa.4, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

75. Clinical significance of serum leptin level in patients with gastric cancer

Tas F., Karabulut S., Erturk K., Duranyildiz D.

EUROPEAN CYTOKINE NETWORK , cilt.29, sa.2, ss.52-58, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

76. Plantar melanoma is associated with certain poor prognostic histopathological factors, but not correlated with nodal involvement, recurrence, and worse survival.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico , cilt.20, sa.5, ss.607-612, 2018 (SCI-Expanded, Scopus)

77. Widespread finger skin metastases of melanoma

CLINICAL CASE REPORTS , cilt.6, sa.2, ss.448-449, 2018 (ESCI)

78. Anemia in Cutaneous Malignant Melanoma: Low Blood Hemoglobin Level is Associated with Nodal Involvement, Metastatic Disease, and Worse Survival

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL , cilt.70, sa.2, ss.236-240, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

79. Neurotropism as a prognostic factor in cutaneous melanoma patients.

Neoplasma , cilt.65, sa.2, ss.304-308, 2018 (SCI-Expanded, Scopus)

80. Significant Neutrophilic Emperipolesis in Squamous Cell Carcinoma

Tetikkurt S., Tas F., Emre F., Ozsoy S., Bilece Z. T.

CASE REPORTS IN ONCOLOGICAL MEDICINE , 2018 (ESCI) Sürdürülebilir Kalkınma

81. Acral Lentiginous Melanoma Is Associated with Certain Poor Prognostic Histopathological Factors but May Not be Correlated with Nodal Involvement, Recurrence, and a Worse Survival

PATHOBIOLOGY , cilt.85, sa.4, ss.227-231, 2018 (SCI-Expanded, Scopus)

82. Significance of serum neural precursor cell-expressed developmentally downregulated protein 9 in melanoma

Erturk K., Tas F., Serılmez M., Bilgin E., Duranyıldız D.

MOLECULAR AND CLINICAL ONCOLOGY , cilt.8, sa.1, ss.204-208, 2018 (ESCI, Scopus)

83. Digital clubbing as a first clinical presentation of pulmonary metastases in cutaneous melanoma

POSTGRADUATE MEDICINE , cilt.130, sa.2, ss.278-279, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

84. Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival

MOLECULAR AND CLINICAL ONCOLOGY , cilt.7, sa.6, ss.1083-1088, 2017 (ESCI, Scopus)

85. Effect of biology on the outcome of female melanoma patients

Erturk K., Tas F.

MOLECULAR AND CLINICAL ONCOLOGY , cilt.7, sa.6, ss.1093-1100, 2017 (ESCI, Scopus)

86. Elevated erythrocyte sedimentation rate is associated with metastatic disease and worse survival in patients with cutaneous malignant melanoma

MOLECULAR AND CLINICAL ONCOLOGY , cilt.7, sa.6, ss.1142-1146, 2017 (ESCI, Scopus) Sürdürülebilir Kalkınma

87. Cutaneous Melanoma in Association With Ichthyosis Vulgaris

Tas F., Erturk K., DEMİRKESEN C., Goktay F.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , cilt.39, sa.8, ss.630, 2017 (SCI-Expanded, Scopus)

88. Scalp melanoma is associated with high mitotic rate and is a poor prognostic factor for recurrence and outcome

MELANOMA RESEARCH , cilt.27, sa.4, ss.387-390, 2017 (SCI-Expanded, Scopus)

89. Clinical Signifıcance of Serum Ykl-40 (Chitinase-3-Like-1 Protein) as a Biomarker in Melanoma: an Analysis of 112 Turkish Patients

Erturk K., Tas F., Serılmez M., Bilgin E., Yasasever V.

Asian Pacific journal of cancer prevention : APJCP , cilt.18, ss.1383-1387, 2017 (SCI-Expanded)

90. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors

MELANOMA RESEARCH , cilt.27, sa.2, ss.134-139, 2017 (SCI-Expanded, Scopus)

91. Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma

Afsar C. U., Karabulut M., Karabulut S., Alis H., Gonenc M., Dagoglu N., et al.

JOURNAL OF INFECTION AND CHEMOTHERAPY , sa.4, ss.196-200, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

92. Clinical Significance of Circulating Serum Cellular Heat Shock Protein 90 (HSP90) Level in Patients with Cutaneous Malignant Melanoma

Tas F., Bilgin E., Erturk K., Duranyıldız D.

Asian Pacific journal of cancer prevention : APJCP , cilt.18, ss.599-601, 2017 (SCI-Expanded)

93. Assessment of Anxiety and Depression Status in Turkish Cutaneous Melanoma Patients

Tas F., Karabulut S., Guveli H., Kurul S., Erturk K., Guveli M., et al.

Asian Pacific journal of cancer prevention : APJCP , cilt.18, ss.369-373, 2017 (SCI-Expanded)

94. Histological lymphovascular invasion is associated with nodal involvement, recurrence, and survival in patients with cutaneous malignant melanoma

INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.56, sa.2, ss.166-170, 2017 (SCI-Expanded, Scopus)

95. SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA

Karabulut M., Afsar C. U., Karabulut S., Peker K. D., Gemici E., Dagoglu N., et al.

ACTA MEDICA MEDITERRANEA , sa.4, ss.613-619, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

96. Tumor Infiltrating Lymphocytes (TILs) May be Only an Independent Predictor of Nodal Involvement but not for Recurrence and Survival in Cutaneous Melanoma Patients

CANCER INVESTIGATION , cilt.35, sa.8, ss.501-505, 2017 (SCI-Expanded, Scopus)

97. Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma

Karabulut S., Afsar C. U., Karabulut M., Alis H., Bozkurt M. A., Aydogan F., et al.

BBA CLINICAL , cilt.6, ss.138-142, 2016 (ESCI, Scopus) Sürdürülebilir Kalkınma

98. Presence of histological regression as a prognostic factor in cutaneous melanoma patients.

Melanoma research , cilt.26, ss.492-6, 2016 (SCI-Expanded, Scopus)

99. Clinical significance of serum claudin-1 levels in melanoma patients

Tas F., Bilgin E., Erturk K., Duranyildiz D.

MELANOMA RESEARCH , cilt.26, sa.4, ss.377-381, 2016 (SCI-Expanded, Scopus)

100. Clinical significance of serum laminin and type-IV collagen levels in cutaneous melanoma patients

Tas F., Bılgın E., Karabulut S., Duranyıldız D.

MOLECULAR AND CLINICAL ONCOLOGY , cilt.5, sa.1, ss.195-200, 2016 (ESCI, Scopus)

101. Zosteriform type in-transit metastasis of melanoma

INDIAN JOURNAL OF MEDICAL RESEARCH , cilt.143, ss.143, 2016 (SCI-Expanded)

102. Serum leptin levels may have diagnostic and predictive roles in patients with pancreatic adenocarcinoma treated with gemcitabine-based chemotherapy.

Karabulut S., AFSAR C. U., KARABULUT M., ALIS H., Erturk K., Karaman S., et al.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , cilt.21, sa.4, ss.895-902, 2016 (SCI-Expanded, Scopus)

103. Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer

Ciftci R., Taş F., Bilgin E., Keskin S., Yildiz I., Duranyildiz D., et al.

Journal of Oncological Science , cilt.2, sa.1, ss.7-11, 2016 (Hakemli Dergi) Sürdürülebilir Kalkınma

104. Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients.

Tas F., Bilgin E., Tastekın D., Erturk K., Duranyıldız D.

Journal of gastrointestinal cancer , cilt.47, ss.182-6, 2016 (Scopus) Sürdürülebilir Kalkınma

105. Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma

Tas F., Bilgin E., Karabulut S., Erturk K., Duranyildiz D.

BBA CLINICAL , cilt.5, ss.166-169, 2016 (ESCI, Scopus) Sürdürülebilir Kalkınma

106. Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer

Tas F., Bilgin E., Tastekin D., Erturk K., Duranyildiz D.

BIOMEDICAL REPORTS , cilt.4, sa.5, ss.609-614, 2016 (ESCI, Scopus) Sürdürülebilir Kalkınma

107. Pankreas Adenokanserli Hastalarda Serum Transforme Edici Büyüme Faktör Beta-1 (TGF B1) Düzeyleri

KARABULUT S., KARABULUT M., USUL AFŞAR Ç., ALIŞ H., DAĞOĞLU SAKİN R. N., AKARSU C., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.12, sa.1, ss.24-32, 2016 (Hakemli Dergi)

108. Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies: A Comparison of Chemotherapy-Associated Myelotoxicity in Patients With Advanced Ovarian and Non-Small-Cell Lung Cancer.

Tas F., Yildiz I., Kilic L., Ciftci R., Keskin S., Sen F.

American journal of therapeutics , cilt.23, sa.3, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

109. Clinical significance of serum caveolin-1 levels in melanoma patients

Tas F., Karabulut S., Yasasever C. T., Duranyildiz D.

INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.55, sa.5, ss.558-562, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

110. Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome

Tas F., Bılgın E., Karabulut S., Tastekın D., Duranyıldız D.

MOLECULAR AND CLINICAL ONCOLOGY , cilt.4, sa.4, ss.655-659, 2016 (ESCI, Scopus) Sürdürülebilir Kalkınma

111. Clinical significance of serum protease-activated receptor-1 levels in gastric cancer patients

Tas F., Karabulut S., Tastekin D., Duranyildiz D.

BIOMEDICAL REPORTS , cilt.4, sa.4, ss.489-492, 2016 (ESCI, Scopus) Sürdürülebilir Kalkınma

112. Clinical significance of serum laminin levels in patients with lung cancer

Tas F., Bilgin E., Tastekin D., Erturk K., Duranyildiz D.

BIOMEDICAL REPORTS , cilt.4, sa.4, ss.485-488, 2016 (ESCI, Scopus) Sürdürülebilir Kalkınma

113. Majority of the most-cited articles on cutaneous malignant melanoma are published in non-dermatology/melanoma specialized journals.

Journal of cancer research and therapeutics , cilt.12, ss.612-5, 2016 (SCI-Expanded, Scopus)

114. Pankreas adenokarsinomlu hastalarda serum transforme edici büyüme factor beta 1 TGF B1 düzeyleri

KARABULUT S., KARABULUT M., AFŞAR USUL Ç., ALIŞ H., DAĞOĞLU N., AKARSU C., et al.

İstanbul Tıp Fakültesi Dergisi , cilt.79, sa.1, ss.9-15, 2016 (Hakemli Dergi)

115. Is it solitary plasmacytoma or nonsecretory myeloma? A must-be-solved dilemma?

Erturk K., Tastekin D., Gundogdu G., Tas F., Vatansever S.

BIOMEDICINE & PHARMACOTHERAPY , cilt.77, ss.27-29, 2016 (SCI-Expanded)

116. Exacerbation of psoriasis induced by interferon-alpha treatment for melanoma

Tas F., Atsu N.

CUTANEOUS AND OCULAR TOXICOLOGY , cilt.35, sa.1, ss.83-84, 2016 (SCI-Expanded, Scopus)

117. The predictive and prognostic value evaluation of serum extracellular matrix proteins levels in patients with pancreas adenocarcinoma

Karabulut S., KARABULUT M., ALIS H., Dagoglu N., Tambas M., KAPAN S., et al.

MEDICAL JOURNAL OF BAKIRKOY , sa.1, ss.24-32, 2016 (ESCI) Sürdürülebilir Kalkınma

118. Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer

Tas F., Karabulut S., Serilmez M., KARABULUT M., Duranyildiz D.

CANCER CHEMOTHERAPY AND PHARMACOLOGY , cilt.77, sa.1, ss.127-131, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

119. Pankreas adenokanserli hastalarda serum ekstrasellülermatriks proteinlerininprognostik ve prediktif değerinin araştırılması

KARABULUT S., KARABULUT M., ALIŞ H., DAĞOĞLU R. N., TAMBAŞ M., KAPAN S., et al.

MEDICAL JOURNAL OF BAKIRKOY , cilt.12, sa.1, ss.24-32, 2016 (Scopus)

120. Clinical significance of serum protease activated receptor1 levels in patients with lung cancer

Erturk K., Tastekin D., Bilgin E., Tas F., Disci R., Duranyildiz D.

European Review for Medical and Pharmacological Sciences , cilt.20, sa.2, ss.243-249, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

121. Is serum tenascin-C level potential biomarker in pancreatic adenocarcinoma?

Karabulut S., KARABULUT M., ALIS H., Tambas M., KAPAN S., KONES O., et al.

MEDICAL JOURNAL OF BAKIRKOY , cilt.12, sa.2, ss.76-82, 2016 (ESCI)

122. CIRCULATING MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (MIP1-A) AS A POTENTIAL BIOMARKER FOR THE DIAGNOSIS OF PATIENTS WITH PANCREATIC ADENOCARCINOMA

Karabulut S., Afsar C. U., Karabulut M., Alis H., Binboga S., Ozkara I. O., et al.

ACTA MEDICA MEDITERRANEA , cilt.32, sa.4, ss.1035-1040, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

123. SERUM TRANSFORMING GROWTH FACTOR BETA 1 (TGF-B1) LEVELS IN PANCREATIC ADENOCARCINOMA PATIENTS

Karabulut S., Karabulut M., Usul Afsar C., Alis H., Dagoglu N., Akarsu C., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , sa.1, ss.9-15, 2016 (ESCI, TRDizin) Sürdürülebilir Kalkınma

124. Plasma homocysteine, folate and vitamin B12 levels in patients with lung cancer.

Tastekın D., Erturk K., Bozbey H. U., Olmuscelık O., Kızıltan H., Tuna S., et al.

Experimental oncology , cilt.37, ss.218-22, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

125. Tongue metastasis of melanoma

Tas F., Karabulut S., Yegen G., Onder S., Ciftci R.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.11, sa.3, 2015 (SCI-Expanded, Scopus)

126. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , cilt.36, sa.3, ss.2097-103, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

127. Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.

BIOMEDICINE & PHARMACOTHERAPY , cilt.70, ss.19-23, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

128. CLINICAL SIGNIFICANCE OF CIRCULATING PROINFLAMMATORY CYTOKINE LEVELS IN PATIENTS WITH PANCREATIC ADENOCARCINOMA

Karabulut S., Karabulut M., Afsar C. U., Alis H., Guveli M. E., Unsal M. G., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.78, sa.4, ss.102-109, 2015 (ESCI)

129. Circulating annexin A2 as a biomarker in gastric cancer patients: Correlation with clinical variables

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.

Biomedicine and Pharmacotherapy , cilt.69, ss.237-241, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

130. Combination of Capecitabine and Phenytoin May Cause Phenytoin Intoxication: A Case Report

Ciftci R., Tas F., Karabulut S., CIFTCI S.

AMERICAN JOURNAL OF THERAPEUTICS , cilt.22, sa.1, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

131. D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients.

Kilic L., Yildiz I., Sen F. K., ERDEM M. G., Serilmez M., Keskin S., et al.

Cancer biomarkers : section A of Disease markers , cilt.15, sa.4, ss.405-11, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

132. Clinical significance of serum epidermal growth factor receptor (EGFR) levels in patients with breast cancer

Tas F., Bilgin E., Karabulut S., Duranyildiz D.

CYTOKINE , cilt.71, sa.1, ss.66-70, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

133. Clinical significance of serum epithelial cell adhesion molecule (EPCAM) levels in patients with lung cancer

Tas F., Karabulut S., Duranyildiz D.

MOLECULAR AND CELLULAR BIOCHEMISTRY , cilt.396, ss.307-312, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

134. Clinical significance of serum fibronectin and vitronectin levels in melanoma patients

Tas F., Karabulut S., Bilgin E., Tastekin D., Duranyildiz D.

MELANOMA RESEARCH , cilt.24, sa.5, ss.475-479, 2014 (SCI-Expanded, Scopus)

135. Clinical significance of serum M30 and M65 levels in patients with breast cancer

Tas F., Karabulut S., Yildiz I., Duranyildiz D.

BIOMEDICINE & PHARMACOTHERAPY , cilt.68, sa.8, ss.1135-1140, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

136. The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer

Karabulut S., Tas F., Tastekin D., KARABULUT M., Yasasever C., Ciftci R., et al.

TUMOR BIOLOGY , cilt.35, sa.9, ss.8849-8860, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

137. Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer

Tas F., Karabulut S., Bilgin E., Tastekin D., Duranyildiz D.

TUMOR BIOLOGY , cilt.35, sa.9, ss.9303-9309, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

138. The Behavior of Turkish Cancer Patients in Fasting During the Holy Month of Ramadan

Tas F., Karabulut S., Ciftci R., Yildiz I., Keskin S., Kilic L., et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , cilt.44, sa.8, ss.705-710, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

139. Serum levels of vascular cell adhesion molecule-1 (VCAM-1) may have diagnostic, predictive, and prognostic roles in patients with lung cancer treated with platinum-based chemotherapy

Tas F., Karabulut S., Bilgin E., Duranyildiz D.

TUMOR BIOLOGY , cilt.35, sa.8, ss.7871-7875, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

140. Serum transforming growth factor-beta 1 (TGF-beta 1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma

Tas F., Karabulut S., Yasasever C., Duranyildiz D.

TUMOR BIOLOGY , cilt.35, sa.7, ss.7233-7237, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

141. Clinical significance of serum tenascin-c levels in epithelial ovarian cancer

Didem T., Faruk T., Senem K., Derya D., Murat S., Murat G., et al.

TUMOR BIOLOGY , cilt.35, sa.7, ss.6777-6782, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

142. Clinical significance of serum tenascin-C levels in breast cancer

Tastekin D., Tas F., Karabulut S., Duranyildiz D., Serilmez M., Guveli M., et al.

TUMOR BIOLOGY , cilt.35, sa.7, ss.6619-6625, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

143. Coagulation tests show significant differences in patients with breast cancer

Tas F., Kilic L., Duranyildiz D.

TUMOR BIOLOGY , cilt.35, sa.6, ss.5985-5992, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

144. Clinical significance of serum ADP-ribosylation and NAD glycohydrolase activity in patients with colorectal cancer.

Varol B., ÇOŞKUN Ö., Karabulut S., SERIN K. R., Asoglu O., Albeniz I., et al.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , cilt.35, sa.6, ss.5575-82, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

145. Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy

Tas F., Karabulut S., Ciftci R., Sen F., Sakar B., Disci R., et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY , cilt.73, sa.6, ss.1163-1171, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

146. An analysis of the most-cited research papers on oncology: which journals have they been published in?

TUMOR BIOLOGY , cilt.35, sa.5, ss.4645-4649, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

147. Is there any diagnostic value of serum protease-activated receptor-1 (PAR1) levels on determination of epithelial ovarian carcinoma?

Karabulut S., Aksit E., Tas F., Ciftci R., Aydiner A., Yildiz I., et al.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , cilt.35, sa.5, ss.4323-9, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

148. Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer

Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.

TUMOR BIOLOGY , cilt.35, sa.4, ss.3125-3132, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

149. Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients

Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.

TUMOR BIOLOGY , cilt.35, sa.4, ss.3327-3331, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

150. Clinical significance of serum transforming growth factor-beta 1 (TGF-beta 1) levels in patients with epithelial ovarian cancer

Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.

TUMOR BIOLOGY , cilt.35, sa.4, ss.3611-3616, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

151. Clinical significance of serum epithelial cell adhesion molecule (EPCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in patients with epithelial ovarian cancer

Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.

TUMOR BIOLOGY , cilt.35, sa.4, ss.3095-3102, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

152. Clinical significance of serum hepatocyte growth factor (HGF) levels in hepatocellular carcinoma

Karabulut S., Tas F., Akyuz F., Ormeci A., Serilmez M., Soydinc H. O., et al.

TUMOR BIOLOGY , cilt.35, sa.3, ss.2327-2333, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

153. Recurrent gastric cancer presenting with both scrotal and facial skin metastases: a case report.

Tas F., Ciftci R., Buyukbabani N., Karabulut S.

Journal of gastrointestinal cancer , cilt.45, ss.96-9, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

154. Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma

Karabulut S., Duranyildiz D., Tas F., Gezer U., Akyuz F., Serilmez M., et al.

TUMOR BIOLOGY , cilt.35, sa.3, ss.2729-2739, 2014 (SCI-Expanded, Scopus)

155. Increased serum level of epidermal growth factor receptor (EGFR) is associated with poor progression-free survival in patients with epithelial ovarian cancer

Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.

CANCER CHEMOTHERAPY AND PHARMACOLOGY , cilt.73, sa.3, ss.631-637, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

156. High serum transforming growth factor beta 1 (TGFB1) level predicts better survival in breast cancer

Ciftci R., Tas F., Yasasever C., Aksit E., Karabulut S., Sen F., et al.

Tumor Biology , cilt.35, sa.7, ss.6941-6948, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

157. Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma

Tas F., Karabulut S., Bilgin E., Sen F., Yildiz I., Tastekin D., et al.

TUMOR BIOLOGY , cilt.34, sa.6, ss.3529-3536, 2013 (SCI-Expanded, Scopus)

158. Clinical significance of coagulation assays in metastatic pancreatic adenocarcinoma.

Tas F., Karabulut S., Bilgin E., Kılıc L., Cıftcı R., Duranyıldız D.

Journal of gastrointestinal cancer , cilt.44, ss.404-9, 2013 (SCI-Expanded)

159. The role of surgical methods in the treatment of anorectal malignant melanoma (AMM).

Keskin S., Tas F., Karabulut S., Yildiz I., Kiliç L., Ciftci R., et al.

Acta chirurgica Belgica , cilt.113, ss.429-33, 2013 (SCI-Expanded, Scopus)

160. Age is a prognostic factor affecting survival in lung cancer patients

Tas F., Ciftci R., Kilic L., Karabulut S.

ONCOLOGY LETTERS , cilt.6, sa.5, ss.1507-1513, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

161. Performance status of patients is the major prognostic factor at all stages of pancreatic cancer

Tas F., Sen F., Odabas H., Kilic L., Keskin S., Yildiz I.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , cilt.18, sa.5, ss.839-846, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

162. Clinical significance of serum M30 and M65 levels in melanoma

Tas F., Karabulut S., Serilmez M., Yildiz I., Sen F., Ciftci R., et al.

MELANOMA RESEARCH , cilt.23, sa.5, ss.390-395, 2013 (SCI-Expanded, Scopus)

163. Clinical and prognostic significance of coagulation assays in gastric cancer.

Tas F., Ciftci R., Kilic L., Serilmez M., Karabulut S., Duranyildiz D.

Journal of gastrointestinal cancer , cilt.44, ss.285-92, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

164. Patellar metastasis of melanoma

INDIAN JOURNAL OF MEDICAL RESEARCH , cilt.138, ss.370, 2013 (SCI-Expanded, Scopus)

165. A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer

Yildiz I., Tas F., Kilic L., Sen F., Saip P., Eralp Y., et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY , cilt.72, sa.2, ss.437-444, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

166. Biweekly triplet chemotherapy with gemcitabine, cisplatin and vinorelbine for advanced chemotherapy naïve non-small cell lung cancer.

Keskin S., Tas F., Ekenel M., Kilic L., Sen F., Yildiz I., et al.

Tumori , cilt.99, sa.4, ss.463-8, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

167. Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival.

Tas F., Sen F., Keskin S., Kilic L., Yildiz I.

Molecular and clinical oncology , cilt.1, ss.788-792, 2013 (ESCI) Sürdürülebilir Kalkınma

168. Oral etoposide as first-line therapy in the treatment of patients with advanced classic Kaposi's sarcoma (CKS): a single-arm trial (oral etoposide in CKS)

Tas F., Sen F., Keskin S., Kilic L.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , cilt.27, sa.6, ss.789-792, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

169. Mucosal melanoma in the head and neck region: different clinical features and same outcome to cutaneous melanoma.

ISRN dermatology , cilt.2013, ss.586915, 2013 (Hakemli Dergi)

170. Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapy-naive advanced non-small cell lung cancer

Tas F., Sen F., Guney N., Keskin S., Camlica H.

ONCOLOGY LETTERS , cilt.5, sa.5, ss.1699-1703, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

171. Clinical and prognostic significance of coagulation assays in lung cancer

Tas F., Kilic L., Serilmez M., Keskin S., Sen F., Duranyildiz D.

RESPIRATORY MEDICINE , cilt.107, sa.3, ss.451-457, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

172. Clinical and Prognostic Significance of Coagulation Assays in Advanced Epithelial Ovarian Cancer

Tas F., Kilic L., Bilgin E., Keskin S., Sen F., Ciftci R., et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , cilt.23, sa.2, ss.276-281, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

173. Adrenocortical carcinoma: clinicopathological features, prognostic factors and outcome.

Keskin S., Tas F., Vatansever S.

Urologia internationalis , cilt.90, sa.4, ss.435-8, 2013 (SCI-Expanded, Scopus)

174. Clinical and prognostic significance of coagulation assays in melanoma

Tas F., Ciftci R., Kilic L., Bilgin E., Keskin S., Sen F., et al.

MELANOMA RESEARCH , cilt.22, sa.5, ss.368-375, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

175. Age-specific incidence ratios of lung cancer (LC) in Turkey: LC in older people is increasing

ARCHIVES OF GERONTOLOGY AND GERIATRICS , cilt.55, sa.2, ss.276-278, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

176. Association of clinical and pathological variables with survival in thymoma.

Aydiner A., Toker A., Sen F., Bicakci E., Saglam E. K., Erus S., et al.

Medical oncology (Northwood, London, England) , cilt.29, sa.3, ss.2221-8, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

177. Age-specific incidence ratios of colorectal cancer (CRC) in Turkey: CRC in older people is increasing

ARCHIVES OF GERONTOLOGY AND GERIATRICS , cilt.55, sa.2, ss.279-282, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

178. Age-specific incidence ratios of breast cancer (BC) in Turkey: BC in older people is increasing

ARCHIVES OF GERONTOLOGY AND GERIATRICS , cilt.55, sa.1, ss.112-115, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

179. The major stressful life events and cancer: stress history and cancer

Tas F., Karalar U., Aliustaoglu M., Keskin S., Can G., Cinar F. E.

MEDICAL ONCOLOGY , cilt.29, sa.2, ss.1371-1377, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

180. The roles of surgery and EMA/CO chemotherapy regimen in primary refractory and non-refractory gestational trophoblastic neoplasia

Aydiner A., Keskin S., Berkman S., Bengisu E., Ilhan H. R., Tas F., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.138, sa.6, ss.971-977, 2012 (SCI-Expanded, Scopus)

181. Küçük Hücreli Akciğer Kanserinde Anjiogenik Faktörler (VEGF, VEGFR-1, VEGFR-2)

OĞUZ SOYDİNÇ H., DURANYILDIZ D., BILGIN E., TAŞ F., YASASEVER V.

TÜRK ONKOLOJİ DERGİSİ , cilt.27, sa.2, ss.55-61, 2012 (Scopus) Sürdürülebilir Kalkınma

182. Factors Influencing the Hormone Receptor and HER2 Levels in Breast Cancer: A Population-Based Analysis

ONKOLOGIE , cilt.35, sa.3, ss.95-98, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

183. Classic Kaposi's sarcoma with colonic involvement: a rare presentation with successful treatment with oral etoposide.

Tas F., Keskın S., Yegen G., Gozubuyukoglu N.

Journal of cancer research and therapeutics , cilt.8, ss.112-3, 2012 (SCI-Expanded, Scopus)

184. Angiogenic factors in small veil lung cancer (VEGF, VEGFR-1, VEGFR-2)

OĞUZ SOYDİNÇ H., DURANYILDIZ H. D., Bilgin E., TAŞ F., Yasasever V.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.27, sa.2, ss.55-61, 2012 (ESCI) Sürdürülebilir Kalkınma

185. Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors.

Journal of oncology , cilt.2012, ss.647684, 2012 (SCI-Expanded, Scopus)

186. Melanoma-associated hypopigmentation in association with locoregional relapse of melanoma

SURGERY , cilt.150, sa.5, ss.1011-1012, 2011 (SCI-Expanded, Scopus)

187. Induction Chemotherapy With Triweekly Docetaxel and Cisplatin Followed by Concomitant Chemoradiotherapy With or Without Surgery in Stage III Non-Small-Cell Lung Cancer: A Phase II Study

Aydiner A., Sen F., SAGLAM E. K., Oral E. N., Eralp Y., Tas F., et al.

CLINICAL LUNG CANCER , cilt.12, sa.5, ss.286-292, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

188. Matrix metalloproteinase-9 decreased after chemotherapy in patients with non-small cell lung cancer

Ertan E., Soydinc H., YAZAR A., Ustuner Z., Tas F., Yasasever V.

TUMORI , cilt.97, sa.3, ss.286-289, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

189. Age-specific Incidence Ratios in Malignant Melanoma in Turkey: Melanoma in Older People is Increasing

ACTA DERMATO-VENEREOLOGICA , cilt.91, sa.3, ss.353-354, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

190. Noncutaneous Melanoma Have Distinct Features from Each Other and Cutaneous Melanoma

Tas F., Keskin S., Karadeniz A., Dagoglu N., Sen F., Kilic L., et al.

ONCOLOGY , sa.5-6, ss.353-358, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

191. Cardiac involvement in melanoma: a case report and review of the literature.

Tas F., Mudun A., KIRMA C.

Journal of cancer research and therapeutics , cilt.6, sa.3, ss.359-61, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

192. Primary mucosal malignant melanoma of the nasopharynx: two case reports

Karadeniz A., Gurocak S., Biliciler N., BAŞARAN M., TAŞ F.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.24, sa.3, ss.131-137, 2009 (ESCI)

193. Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma

Tas F., Duranyildiz D., Oguz H., Camlica H., Yasasever V., Topuz E.

MEDICAL ONCOLOGY , cilt.25, sa.4, ss.431-436, 2008 (SCI-Expanded, Scopus)

194. Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer.

Topuz E., DERIN D., CAN G., Kuerklue E., Cinar S., Aykan F., et al.

Investigational new drugs , cilt.26, sa.6, ss.567-72, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

195. Statistical Interpretation of CA125 and Bcl-2 in Serum of Patients With Late Stage Ovarian Cancer

Camlica H., Duranyildiz D., Tas F., Yasasever V.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , cilt.31, sa.6, ss.585-588, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

196. The contribution of countries and world regions in productivity of oncological publication.